Tuesday, Sep 21 2021 | Time 14:34 Hrs(IST)
image
Business Economy


Emcure Pharma strengthens its board

Kolkata, Jul 27(UNI) Emcure Pharmaceuticals Ltd, one of India’s leading pharma players continues to strengthen its leadership with the appointment of distinguished professionals to its board of directors.
The company has recently added four independent directors with a wealth of knowledge and experience in various fields.
The new additions include Dr Shailesh Ayyangar, Vijay Gokhale, Hitesh Jain and Dr Vidya Yeravdekar. Earlier this year, Berjis Desai had taken over the chairman of the Emcure Board. The company has had a long-standing tradition of appointing a Chairman from amongst its independent directors since 1997.
Emcure aims to further augment its strengths as one of the fastest-growing pharmaceutical companies in India with a global reach of over 70 countries across the world. These additions to the leadership team for Emcure Pharmaceuticals, reflect its commitment towards enriching its expertise
and strengthening its operations for future growth. The new members’ collective strength across legal, pharma spectrum, policy developments and academics will provide additional thrust to Emcure’s
growth trajectory.
Commenting on the appointments, Satish Mehta, Managing Director & CEO, Emcure Pharmaceuticals said, “We are delighted to have highly accomplished industry stalwarts as part of our board. New members’ combined experience and wider perspective from their respective fields, will
play an instrumental role in strengthening our strategic operations to grow in domestic and international markets. It is an exciting time for the organization, and we look forward to achieving newer heights with our new members on board.”
Dr Shailesh Ayyangar appointed as Additional Director comes with an extensive experience of 34 years in healthcare and pharmaceutical. Vijay Gokhale appointed as Independent Director was in the Indian Foreign Service since 1981. Hitesh Jain, appointed as Independent Director is an alumnus of
the London School of Economics in 1996. Dr Vidya Yeravdekar appointed as Independent Director is the Principal Director of Symbiosis Society and the Pro-Chancellor of Symbiosis International University.
UNI XC BM
More News

PDS Multinational Fashions appoints Raamann Ahuja as Group Chief Human Resources Officer

21 Sep 2021 | 1:28 PM

Mumbai, Sep 21 (UNI) PDS Multinational Fashions, a design-led sourcing, manufacturing & supply chain platform has appointed Raamann Ahuja as Group Chief Human Resources Officer (CHRO).

see more..

Yulu partners with Adani Electricity

21 Sep 2021 | 1:28 PM

Mumbai, Sep 21 (UNI) Yulu, the country’s largest e-mobility service provider, has partnered with Adani Electricity Mumbai Limited (AEML) with the common objective of working towards building a sustainable city by reducing traffic congestion and air pollution in Mumbai.

see more..
Ravi Raghavan elected President as IMTMA completes 75 Years

Ravi Raghavan elected President as IMTMA completes 75 Years

21 Sep 2021 | 12:43 PM

Bengaluru, Sep 21 (UNI) The Indian Machine Tool Manufacturers’ Association (IMTMA) held its 75th Annual General Meeting (AGM) on the digital platform.

see more..

Muthoottu Mini NCDs oversubscribed to tune of Rs 108 crore

21 Sep 2021 | 12:23 PM

Kochi, Sep 21 (UNI) Muthoottu Mini Financiers Limited's issue of Non-Convertible Debentures (NCDs) was oversubscribed to the tune of Rs 108 crore.

see more..
Glenmark Pharma receives final approval for clindamycin phosphate foam from USFDA

Glenmark Pharma receives final approval for clindamycin phosphate foam from USFDA

21 Sep 2021 | 12:05 PM

Mumbai, Sep 21 (UNI) Pharma major, Glenmark Pharma on Tuesday said that it has received final approval from the United States Food & Drug Administration for clindamycin phosphate foam 1 %
Clindamycin phosphate foam is the generic version of evoclin foam of Mylan Pharmaceuticals Inc.

see more..
image